Product Description
Mechanisms of Action: Fungal Growth Inhibitor, KV7 Inhibitor
Novel Mechanism: Yes
Modality: Small Molecule
Route of Administration: N/A
FDA Designation: *
Approval Status: Not Approved
Approved Countries: Chile | India | Malaysia | Morocco | Philippines | Russia | Sri Lanka | Taiwan | United Arab Emirates | Venezuela
Approved Indications: None
Known Adverse Events: None
Company: Syntopix Group
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 1: Acne Vulgaris
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
2007-000232-12 |
Antibacterial efficacy of novel topical therapies for acne | P1 |
Completed |
Acne Vulgaris |
2007-07-02 |
2022-03-12 |
Treatments |